发明名称 |
METHOD AND COMPOSITIONS FOR ADMINISTERING TAXANES ORALLY TO HUMAN PATIENTS |
摘要 |
Taxane antineoplastic agents which have heretofore exhibited poor or non-existent oral bioavailability are administered orally to human patients suffering from taxane-responsive disease conditions and made sufficiently bioavailable to achieve therapeutic blood levels. In a preferred embodiment, the taxane, preferably paclitaxel, is co-administered to the patient with an oral cyclosporin enhancing agent, preferably cyclosporin A. By one preferred method, a dose of oral enhancer is administered about 0.5-72 hours before the taxane and a second dose of the enhancer and administered immediately before, together with or immediately after the taxane. A method of treating human patients suffering from taxane-responsive disease conditions is also provided, as well as a method for providing such treatment while preventing or reducing hypersensitivity and allergic reactions without the need for pre-medication.
|
申请公布号 |
WO9853811(A1) |
申请公布日期 |
1998.12.03 |
申请号 |
WO1998US07776 |
申请日期 |
1998.04.22 |
申请人 |
BAKER NORTON PHARMACEUTICALS, INC. |
发明人 |
BRODER, SAMUEL;DUCHIN, KENNETH, L.;SELIM, SAMI |
分类号 |
A61K38/00;A61K31/337;A61K38/13;A61P35/00;(IPC1-7):A61K31/335 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|